KRAS and colorectal carcinoma: KRAS/BRAF mutational status is also implicated in mitochondrial activity of CRC with KRAS mutants having lower ADP-activated respiration rate than KRAS/BRAF wt and unchanged outer membrane permeability, suggesting an oxidative phenotype.